HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sriram Shanmugavelandy Selected Research

Carbon-13

11/2017Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sriram Shanmugavelandy Research Topics

Disease

2Prostatic Neoplasms (Prostate Cancer)
01/2019 - 11/2017
2Neoplasms (Cancer)
01/2019 - 11/2017
1Leukemia
06/2013

Drug/Important Bio-Agent (IBA)

2Pyruvic Acid (Pyruvate)IBA
01/2019 - 11/2017
1AndrogensIBA
01/2019
1Lactic Acid (Lactate)FDA LinkGeneric
01/2019
1Androgen Receptors (Androgen Receptor)IBA
01/2019
1Carbon-13IBA
11/2017
1Glutamine (L-Glutamine)FDA Link
11/2017
1N-caproylsphingosineIBA
06/2013
1ceramide glucosyltransferaseIBA
06/2013

Therapy/Procedure

1Castration
01/2019
1Drug Therapy (Chemotherapy)
01/2019
1Therapeutics
01/2019
1Precision Medicine
11/2017